Conditions: Urinary Bladder, Overactive
Keywords: Frequency YM178 Overactive bladder (OAB) Micturition Urgency Urinary urge incontinence Urinary incontinence
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 2149
Healthy volunteers: no

Brief summary:
The study is intended to test the efficacy, safety and tolerability of two doses of mirabegron against placebo to treat patients with symptoms of overactive bladder

Detailed description:

Arms:
arm 1: Participants received matching placebo tablets orally once a day for 12 weeks arm 2: Participants received mirabegron 50 mg tablets orally once a day for 12 weeks arm 3: Participants received mirabegron 100 m tablets, orally once a day for 12 weeks

Interventions: intervention 1: Mirabegron intervention 2: Placebo
Intervention descriptions: intervention 1: Oral intervention 2: Oral

Protocol document: